Ovarian Cancer Second Edition /
Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics. Ovarian carcinogenesis, invasion, and...
Corporate Author: | |
---|---|
Other Authors: | , |
Format: | Electronic |
Language: | English |
Published: |
Boston, MA :
Springer US,
2010.
|
Edition: | 2. |
Series: | Cancer Treatment and Research,
149 |
Subjects: | |
Online Access: | https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-0-387-98094-2 |
Table of Contents:
- Chemoprevention of Ovarian Cancer
- Staging and Surgical Treatment
- Novel Therapeutic Targets
- Biomarker Targets and Novel Therapeutics
- Tumor Suppressor Genes
- Epigenetics and Ovarian Cancer
- Aberrant Epithelial Differentiation in Ovarian Cancer
- The Human Kallikrein Gene Family
- Soluble Epidermal Growth Factor Receptor (sEGFR)
- Activated Epidermal Growth Factor Receptor in Ovarian Cancer
- Ras-Superfamily GTP-ases in Ovarian Cancer
- Lipid Generation and Signaling in Ovarian Cancer
- LPA and Invasion
- Cell Adhesion in Ovarian Cancer
- Microenvironmental Regulation of Ovarian Cancer Metastasis
- Organotypic Models of Metastasis
- Animal Models of Ovarian Cancer
- Index.